Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03034096 · ClinicalTrials.gov registry record · Phase 4
General Anesthetics in CAncer REsection Surgery (GA-CARES) Trial
A Phase 4 study, sponsored by Stony Brook University.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,826
- Enrollment target
NCT03034096: Completed Phase 4 study, sponsored by Stony Brook University.
NCT03034096 is a Phase 4 study that has completed, run by Stony Brook University. The registered enrollment target is 1,826 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (253% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03034096, a Phase 4 study, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,826 participants
- Enrollment target
Study Summary
This is a large pragmatic multicenter trial comparing maintenance of general anesthesia with total intravenous anesthesia using propofol versus volatile agent (sevoflurane, isoflurane, or desflurane) during cancer surgery. The primary endpoint is all-cause mortality.
Primary Outcome
Time to event
Interventions
- DRUG Propofol
- DRUG Volatile Agent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,826 participants |
| Start Date | 2017-01-31 |
| Est. Completion | 2024-09-30 |
| Phase | Phase 4 |
What the finished NCT03034096 record still lists
NCT03034096 is an interventional study that assigns participants to a tested intervention. Its 1,826 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (253% higher).
The record links to 0 conditions, and to 2 interventions - of which Propofol is the first listed.
NCT03034096 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03034096 about?
NCT03034096 is a clinical study titled "General Anesthetics in CAncer REsection Surgery (GA-CARES) Trial". This is a large pragmatic multicenter trial comparing maintenance of general anesthesia with total intravenous anesthesia using propofol versus volatile agent (sevoflurane, isoflurane, or desflurane) during cancer surgery. The primary endpoint is all-cause mortality.
What is the current status of trial NCT03034096?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,826 participants. The study started on 2017-01-31. Estimated completion is 2024-09-30.
What interventions are being tested in trial NCT03034096?
The interventions under investigation include: Propofol (DRUG), Volatile Agent (DRUG).
Who is sponsoring clinical trial NCT03034096?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03034096's enrollment target sits among peer trials
1,826 45th of 2000 higher than 1,956 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07104240 · 1,836 participants · NA
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
- NCT06740630 · 1,840 participants · Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
- NCT05897788 · 1,808 participants · NA
Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement
- NCT05935007 · 1,805 participants
Aveir DR Real-World Evidence Post-Approval Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI